- Home
- UDMY vs MDXG Comparison
UDMY vs MDXG Comparison
Compare UDMY & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- MDXG
- Stock Information
- Founded
- UDMY 2009
- MDXG 2006
- Country
- UDMY United States
- MDXG United States
- Employees
- UDMY N/A
- MDXG N/A
- Industry
- UDMY Other Consumer Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- UDMY Real Estate
- MDXG Health Care
- Exchange
- UDMY Nasdaq
- MDXG Nasdaq
- Market Cap
- UDMY 1.1B
- MDXG 1.0B
- IPO Year
- UDMY 2021
- MDXG N/A
- Fundamental
- Price
- UDMY $6.45
- MDXG $7.27
- Analyst Decision
- UDMY Buy
- MDXG Buy
- Analyst Count
- UDMY 10
- MDXG 1
- Target Price
- UDMY $9.89
- MDXG $12.00
- AVG Volume (30 Days)
- UDMY 1.8M
- MDXG 650.1K
- Earning Date
- UDMY 10-28-2025
- MDXG 10-29-2025
- Dividend Yield
- UDMY N/A
- MDXG N/A
- EPS Growth
- UDMY N/A
- MDXG N/A
- EPS
- UDMY N/A
- MDXG 0.21
- Revenue
- UDMY $795,538,000.00
- MDXG $363,774,000.00
- Revenue This Year
- UDMY $2.58
- MDXG $12.68
- Revenue Next Year
- UDMY $4.19
- MDXG $8.18
- P/E Ratio
- UDMY N/A
- MDXG $34.82
- Revenue Growth
- UDMY 3.93
- MDXG 6.85
- 52 Week Low
- UDMY $5.68
- MDXG $5.47
- 52 Week High
- UDMY $10.61
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- UDMY 34.92
- MDXG 56.76
- Support Level
- UDMY $6.88
- MDXG $6.62
- Resistance Level
- UDMY $6.98
- MDXG $7.04
- Average True Range (ATR)
- UDMY 0.24
- MDXG 0.23
- MACD
- UDMY -0.06
- MDXG 0.02
- Stochastic Oscillator
- UDMY 1.74
- MDXG 86.52
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.